Evidence map›Paper›PMID 31372346›Full record

ArticleToxicology reports2019

Renoprotective effects of stevia (

Farhana Rizwan, Saquiba Yesmine, Sultana Gulshan Banu, Ishtiak Ahmed Chowdhury, Rajibul Hasan, Tapan Kumar Chatterjee

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. The progress on stevia (Frontiers in nutrition · 2026
    Review
  2. Article
  3. Article
  4. Frontiers in pharmacology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Farhana RizwanDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
Saquiba YesmineDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Sultana Gulshan BanuDepartment of Pathology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.
Ishtiak Ahmed ChowdhuryDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Rajibul HasanDepartment of Biochemistry and Cell Biology, Bangladesh University of Health Sciences, Mirpur, 1216, Dhaka, Bangladesh.
Tapan Kumar ChatterjeeDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
Jadavpur University · INJahangirnagar University · BDBangabandhu Sheikh Mujib Medical University · BDBangladesh University of Health Sciences · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study investigated the renoprotective effects of stevia, angiotensin-II type 1 receptor (AT

Indexed as

ACE, angiotensin converting enzymeARBARB, angiotensin-II type 1 receptor (AT1) blockersAT1, angiotensin-II type 1 receptorAT2, angiotensin-II type 2 receptorBUN, blood urea nitrogenCCBCCB, calcium (Ca2+) channel blockerCKD, chronic kidney diseaseEDTA, ethylene diamine tetra acetateGentamycin-inducedHb, hemoglobinHCT, hematocritHDL, high density lipoproteinLDL, low density lipoproteinMCHC, mean corpuscular hemoglobin concentrationMCH, mean corpuscular hemoglobinMCV, mean corpuscular volumeNephrotoxicityRBC, red blood cellsRBS, random blood sugarRDW-CV, red blood cell distribution width-CVRDW-SD, red blood cell distribution width-SDRenoprotective effectsROS, reactive oxygen speciesSGOT, serum glutamic oxaloacetic transaminaseSGPT, serum glutamic pyruvic transaminaseSteviaTG, triglycerides

Identifiers

PMID31372346
PMCPMC6656923
OpenAlexW2958925537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.